Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Delivers district-scale consolidation by combining GMIN’s Oko West Project and G2’s Oko-Ghanie Project into a single, highly synergistic, Tier-1, Oko Project. Combines anticipated LOM average gold...
-
Delivers district-scale consolidation by combining GMIN’s Oko West Project and G2’s Oko-Ghanie Project into a single, highly synergistic, Tier-1, Oko Project. Combines anticipated LOM average gold...
-
WINNIPEG, Manitoba, April 08, 2026 (GLOBE NEWSWIRE) -- The North West Company Inc. (the "Company" or "North West") today announces its unaudited financial results for the fourth quarter ended...
-
Patent Expands Protection for the Company’s RenovoCath Device, the Novel Dual-Occlusion Catheter-Based System RenovoRx Currently Holds a Strong and Growing Global Intellectual Property Portfolio...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In CHOW To Contact Him Directly To Discuss Their Options If you purchased or acquired CHOW...
-
New class action for Chowchow (CHOW) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/12/2026
-
BENSALEM, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
-
LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 12, 2026 deadline to file a lead plaintiff motion in the class action...
-
New class action for Chow (CHOW) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/12/2026.
-
MOUNTAIN VIEW, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and...